Prevention of relapse in residual depression by cognitive therapy. A controlled trial

Archives of General Psychiatry

Volumn 56, Issue 9, 1999, Pages 829-835

  Paykel, Eugene S ^a   Scott, Jan ^b   Teasdale, John D ^d   Johnson, Anthony L ^d   Garland, Anne ^c   Moore, Richard ^a   Jenaway, Alison ^a   Cornwall, Peter L ^c   Hayhurst, Hazel ^a   Abbott, Rosemary ^a   Pope, Marie ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FLUOXETINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; REMISSION; SYMPTOMATOLOGY; COMPARATIVE STUDY; DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; HUMANS; MALE; RECURRENCE; TREATMENT OUTCOME;

EID: 0032881073     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.56.9.829     Document Type: Article

References (35)

1. Keller MB, Klerman G., Lavori PW, Coryell W, Endicott J, Taylor J. Long-term outcome of episodes of major depression: clinical and public health significance. JAMA. 1984;252:788-792.
2. Lee AS, Murray RM. The long-term outcome of Maudsley depressives. Br J Psychiatry. 1988;153:741-751.
3. Surtees PG, Barkley C. Future imperfect: the long-term outcome of depression. Br J Psychiatry. 1994;164:327-341.
4. Ramana R, Paykel ES, Cooper Z, Hayhurst H, Saxty M, Surtees PG. Remission and relapse in major depression: a two-year prospective follow-up study. Psychol Med. 1995;25:1161-1170.
5. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995;25:1171-1180.
6. Faravelli C, Ambonetti A, Palanti S, Pazzapli A. Depressive relapses and incomplete recovery from index episode. Am J Psychiatry. 1986;49:888-891.
7. Georgotas A, McCue R, Cooper TB, Hagachandran N, Chang I. How effective and safe is continuation therapy in elderly depressed patients: factors affecting relapse rate. Arch Gen Psychiatry. 1988;45:929-932.
8. Mindham RH, Howland C, Shepherd M. An evaluation of continuation therapy with Iricyclic antidepressants in depressive illness. Psychol Med. 1973;3:5-17.
9. Prien RF, Kupfer DJ. Continuous drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry. 1986;143:18-23.
10. Simons AD, Murphy GE, Levine J, Wetzel RD. Cognitive therapy and pharmacotherapy of depression: sustained improvement over one year. Arch Gen Psychiatry. 1986;43:43-50.
11. Evans MD, Hollon SD, De Rubeis RJ, Piasecki JM, Grove WM, Garvey MJ, Tuason VB. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry. 1992;49:802-808.
12. Thase ME, Simons AD, McGeary J, Cahalane JF, Hughes C, Harden T, Friedman E. Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry. 1992;149:1046-1052.
13. Blackburn IM, Eunson KM, Bishop S. A two year naturalistic follow up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affect Disord. 1986;10:67-75.
14. Blackburn I, Moore R. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in outpatients with recurrent depression. Br J Psychiatry. 1997;171:328-334.
15. Fava GA, Rafanelli C, Grandi S, Canestrari R, Morphy MA. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry. 1998;155:1443-1445.
16. Fava GA, Rafanelli C, Grandi S, Conti S, Belluardo P. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry. 1998;55:816-820.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, Washington, DC: American Psychiatric Association; 1987.
18. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
19. Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK. An inventory for measuring depression. Arch Sen Psychiatry. 1961;4:561-571.
20. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse and recurrence. Arch Gen Psychiatry. 1991;48:851-855.
21. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Grass DR, Pilkonis PA, Lever WR, Docherty JP, Fiester SJ, Parloff MB. National Insitute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatment. Arch Gen Psychiatry. 1989;46:971-982.
22. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York, NY: John Wiley & Sons; 1979.
23. Young J, Beck AT. Manual of the Cognitive Therapy Rating Scale. Pittsburgh, Pa: Penn University Center for Cognitive Therapy; 1990.
24. Beck AT, Freeman A. Cognitive Therapy tor Personality Disorders. New York, NY: Guildford Press; 1994.
25. Endicott J, Spitzer RL A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1978;37:837-844.
26. Eysenck HJ, Eysenck SBG. Manual of the Eysenck Personality Inventory. London, England: University of London Press; 1964.
27. Cornwall P, Scott J. Partial remission in depression. Acta Psychiatr Scand. 1997; 95:265-271.
28. Kovacs M, Rush AJ, Beck AT, Hollon SD. Depressed outpatients treated with cognitive therapy or pharmacotherapy. Arch Gen Psychiatry. 1981;38:33-41.
29. Miller IW, Norman WG, Keitner GI. Cognitive-behavioral treatment of depresssed inpatients: six- and twelve-month follow-up. Am J Psychiatry. 1989; 146:1274-1279.
30. Shea MT, Elkin I, Linber S, Sotsky S, Watkins J, Collins J, Pilkonis P, Beckham E, Glass D, Dolan R, Parioff M. Course of depressive symptoms over follow-up. Arch Gen Psychiatry. 1992;49:782-787.
31. Hollon S, Beck AT. Cognitive and cognitive behavior therapies. In: Garfield S, Bergin A, eds. Handbook of Psychotherapy and Behavior Change. New York, NY: John Wiley & Sons; 1995.
32. Fava GA, Grandi S, Zielezny M, Canstrari R, Morphy MA. Cognitive behavioural treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry. 1994;151:1295-1299.
33. Fava GA, Grandi S, Zielezny M, Rafanelli C, Canestrari R. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry. 1996;153:945-947.
34. Frank E, Kupfer DJ, Perel JM, Cornes C, Jarret DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1990;47:1093-1099.
35. Hollon S, Skelton R, Davies D. Cognitive therapy for depression: conceptual issues and clinical efficacy. J Consult Clin Psychol. 1993;61:270-275.